Guidelines for the management and treatment of periodic fever syndromes: periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome  by Terreri, Maria Teresa R.A. et al.





Guidelines  for  the management  and  treatment  of
periodic fever  syndromes:  periodic  fever, aphthous
stomatitis, pharyngitis  and  adenitis  syndrome
Maria Teresa R.A. Terreria,∗, Wanderley Marques Bernardob, Claudio Arnaldo Lena,
Clovis  Artur Almeida da Silvac, Cristina Medeiros Ribeiro de Magalhãesd,
Silvana  B. Sacchetti e, Virgínia Paes Leme Ferriani f, Daniela Gerent Petry Piottoa,
André  de Souza Cavalcantig, Ana Júlia Pantoja de Moraesh, Flavio Roberto Sztajnbok i,
Sheila  Knupp Feitosa de Oliveira j, Lucia Maria Arruda Camposc, Marcia Bandeirak,
Flávia  Patricia Sena Teixeira Santos l, Claudia Saad Magalhãesm
a Sector of Pediatric Rheumatology, Department of Pediatrics, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil
b Center for Development of Medical Teaching, Medicine School, Universidade de São Paulo (USP), São Paulo, SP, Brazil
c Pediatric Rheumatology Unit, Children’s Institute, Medicine School, Universidade de São Paulo (USP), São Paulo, SP, Brazil
d Hospital da Crianc¸a de Brasília José Alencar (HCB), Brasília, DF, Brazil
e Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brazil
f Service of Immunology, Allergy and Pediatric Rheumatology, Department of Pediatrics, Faculdade de Medicina de Ribeirão Preto,
Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil
g Service of Rheumatology, Hospital das Clínicas, Universidade Federal de Pernambuco (UFPE), Recife, PE, Brazil
h Universidade Federal do Pará (UFPA), Belém, PA, Brazil
i Service of Rheumatology, Nucleus Adolescents’ Health Studies, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil
j Service of Pediatric Rheumatology, Instituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro
(UFRJ), Rio de Janeiro, RJ, Brazil
k Hospital Pequeno Príncipe, Curitiba, PR, Brazil
l Service of Rheumatology, Hospital das Clínicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil
m Pediatric Rheumatology Unit, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista (Unesp), Botucatu, SP, Brazil
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 7 July 2015
Accepted 30 August 2015
Available online 20 October 2015
Keywords:
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Objective: To establish guidelines based on scientiﬁc evidence for the management of peri-
odic  fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome.
Description of the evidence collection method: The Guideline was prepared from 5 clinical ques-
tions that were structured through PICO (Patient, Intervention or indicator, Comparison
and Outcome), to search in key primary scientiﬁc information databases. After deﬁning the
potential studies to support the recommendations, these were graduated considering theirSyndrome of periodic fever,
aphthous stomatitis, pharyngitis,
and cervical adenitis
strength of evidence and grade of recommendation.
Results: 806 articles were retrieved and evaluated by title and abstract; from these, 32 articles
were selected to support the recommendations.
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Recommendations: 1. PFAPA is a diagnosis of exclusion established on clinical grounds, and
one  must suspect of this problem in children with recurrent and periodic febrile episodes
of  unknown origin, or with recurrent tonsillitis interspersed with asymptomatic periods,
especially in children in good general condition and with preservation of weight and
height development. 2. Laboratory ﬁndings are nonspeciﬁc. Additional tests do not reveal
pathognomonic changes. 3. The evidence supporting an indication for surgical treatment
(tonsillectomy with or without adenoidectomy), is based on two non-blinded randomized
clinical trials with small numbers of patients. 4. The use of prednisone at the onset of fever
in  patients with PFAPA proved to be an effective strategy. There is still need for more quali-
ﬁed evidence to support its use in patients with PFAPA. 5. Despite promising results obtained
in  studies with IL-1 inhibitors, such studies are limited to a few case reports.
©  2015 Elsevier Editora Ltda. All rights reserved.
Diretrizes  de  conduta  e  tratamento  de  síndromes  febris  periódicas:
síndrome  de  febre  periódica,  estomatite  aftosa,  faringite  e  adenite
Palavras-chave:
Síndrome de febre periódica,






r  e  s  u  m  o
Objetivo: Estabelecer diretrizes baseadas em evidências cientíﬁcas para manejo da Síndrome
de  febre periódica, estomatite aftosa, faringite e adenite (PFAPA).
Descric¸ão  do método de coleta de evidência: A Diretriz foi elaborada a partir de 5 questões
clínicas que foram estruturadas por meio do P.I.C.O. (Paciente, Intervenc¸ão ou Indicador,
Comparac¸ão  e Outcome), com busca nas principais bases primárias de informac¸ão cientíﬁca.
Após deﬁnir os estudos potenciais para sustento das recomendac¸ões, estes foram graduados
pela  forc¸a da evidência e grau de recomendac¸ão.
Resultados: Foram recuperados, e avaliados pelo título e resumo, 806 trabalhos, sendo sele-
cionados 32 artigos, para sustentar as recomendac¸ões.
Recomendac¸ões: 1. O diagnóstico da PFAPA é clínico e de exclusão, devendo a suspeita ser con-
siderada em crianc¸as que apresentam episódios febris de origem indeterminada recorrentes
e  periódicos ou amidalites de repetic¸ão, intercalados com períodos assintomáticos, sobre-
tudo em crianc¸as em bom estado geral e com desenvolvimento pondero-estatural mantido;
2.  Os achados laboratoriais são inespecíﬁcos. Não existem alterac¸ões patognomônicas nos
exames complementares; 3. A evidência que sustenta a indicac¸ão do tratamento cirúrgico
(tonsilectomia com ou sem adenoidectomia) é baseada em dois ensaios clínicos random-
izados não cegos que incluíram pequeno número de pacientes; 4. O uso de prednisona no
início do quadro febril em pacientes com PFAPA mostrou ser eﬁcaz. Melhores evidências
ainda  são necessárias para apoiar seu uso na PFAPA; 5. Apesar dos resultados obtidos de
estudos com inibidores de IL-1ß serem promissores, estes são limitados a poucos relatos de
casos.















A. Experimental or observational studies of higher consis-escription  of  the  method  of  evidence
ollection
he Guideline was prepared from 5 relevant clinical ques-
ions related to the management of periodic fever, aphthous
tomatitis, pharyngitis and adenitis (PFAPA) syndrome. The
uestions were structured by the use of PICO (Patient, Inter-
ention or indicator, Comparison and Outcome), allowing the
eneration of strategies for searching evidence (described
fter each question, with the number of recovered arti-
les), in the main primary databases of scientiﬁc information
Medline/Pubmed, Embase, Lilacs/Scielo, Cochrane Library).
he recovered evidence has been selected from a critical
valuation using discriminatory instruments (scores): JADAD
nd GRADE for randomized clinical trials, and New CastleOttawa scale for observational studies. After deﬁning the
potential studies to support the recommendations, these arti-
cles were rated based on the strength of evidence and grade
of recommendation, according to the classiﬁcation of Oxford
(available in www.cebm.net), including available evidence of
greatest strength.
Summary  of  grades  of  recommendation
and  strength  of  evidencetency.
B. Experimental or observational studies of lower consis-
tency.
 t o l .54  r e v b r a s r e u m a
C. Case reports (non-controlled studies).
D. Expert opinion without explicit critical appraisal, or based
on physiology or bench research.
Objective
To establish guidelines based on scientiﬁc evidence for the
management of periodic fever, aphthous stomatitis, pharyn-
gitis and adenitis syndrome.
When  should  we  suspect  that  an  individual  is  a  carrier
of periodic  fever,  aphthous  stomatitis,  pharyngitis
and adenitis  syndrome?
Strategy
(Pharyngitis OR Pharyngitides OR Sore Throat OR Lymphadeni-
tis OR Adenitis OR Stomatitis, Aphthous OR Fever OR PFAPA)
AND Periodicity* n = 336.
Described by Marshall for the ﬁrst time in 1987, periodic
fever, aphthous stomatitis, pharyngitis and adenitis syndrome
– PFAPA is the autoinﬂammatory syndrome belonging to the
group of the most common recurrent febrile syndromes in
childhood, although its exact prevalence is not known1 (C).
This is a recurrent, febrile, self-limiting disease, well charac-
terized from a clinical point of view based on case reports
and case series descriptions2 (C). The onset of PFAPA almost
always occurs before the age of ﬁve, and in most patients the
clinical picture resolves spontaneously before 10–12 years of
age. Rare cases have been reported in adulthood3,4 (C). PFAPA
displays a yet unknown etiology, however, increased expres-
sion of genes related to IL-1, interferon and chemokines have
been found during febrile periods5 (D). A signiﬁcant num-
ber of patients with PFAPA syndrome have a positive family
history of recurrence of febrile episodes suggesting a pos-
sible genetic origin; however, no mutation has never been
identiﬁed6 (C).
PFAPA syndrome is characterized by the presence of sud-
den recurrent episodes of high fever, lasting from 2 to 8 days
and which are repeated every 2–12 weeks, accompanied by
aphthous ulcers, pharyngitis, sometimes with exudate, or cer-
vical lymphadenopathy (upper cervical region), with mobile
and painless lymph nodes in the absence of upper respira-
tory tract infection3 (C). Patients usually complain of malaise
hours before the onset of an attack. Pharyngitis and cervi-
cal adenitis are present in 80–100% of these patients, and
aphthous stomatitis can be seen in 60–70%. Other associated
symptoms are abdominal pain, arthralgia, headache, nausea
or vomiting7 (C). For the diagnosis of this syndrome, there is
no need of the presence of the whole group of symptoms, and
one should rule out the possibility of an episode of upper respi-
ratory tract infection; the patient must present asymptomatic
periods between attacks and maintain normal psychomotor
growth and development8 (D).Recommendation
PFAPA is a diagnosis of exclusion established on clinical
grounds, and one must suspect of this problem in children
with recurrent and periodic febrile episodes of unknown 2 0 1 6;5 6(1):52–57
origin, or with recurrent tonsillitis, interspersed with asymp-
tomatic periods, especially in children with a good general
condition and with preservation of weight and height devel-
opment. Other monogenic auto-inﬂammatory diseases such
as a periodic syndrome associated with tumor necrosis factor
receptor (TRAPS) and mevalonate kinase deﬁciency, should be
taken in consideration in the differential diagnosis.
What  tests  should  be  required  for  the  evaluation
of patients  with  periodic  fever,  aphthous  stomatitis,
pharyngitis  and  adenitis  syndrome?
Strategy
(Pharyngitis OR Pharyngitides OR Sore Throat OR Lymphadeni-
tis OR Adenitis OR Stomatitis, Aphthous OR Fever OR PFAPA)
AND Periodicity* AND (Diagnosis/Broad [ﬁlter]) n = 150.
Laboratory ﬁndings are nonspeciﬁc and the diagnosis of
PFAPA syndrome is established on clinical grounds.9 (C).
Although not producing pathognomonic changes, comple-
mentary tests should be requested to support the exclusion of
other diagnoses. Crises are often associated with leukocytosis
and moderate neutrophilia and high erythrocyte sedimenta-
tion rate (ESR) and C-reactive protein (CRP), which normalize
in the intervals between episodes10 (C). Hemoglobin levels
are normal, and platelet levels may be normal or slightly ele-
vated. A tonsil secretion culture may be performed to exclude
diseases that may exhibit similar symptoms, especially strep-
tococcal infection11 (D).
Recommendation
Laboratory ﬁndings are nonspeciﬁc and PFAPA is a diagnosis of
exclusion established on clinical grounds. No  pathognomonic
changes are found with additional tests.
What  is  the  role  of  surgical  approach  (tonsillectomy  with
or without  adenoidectomy)  in  the  treatment  of  periodic
fever,  aphthous  stomatitis,  pharyngitis  and  adenitis
syndrome?
Strategy
(Pharyngitis OR Pharyngitides OR Sore Throat OR Lymphadeni-
tis OR Adenitis OR Stomatitis, Aphthous OR Fever OR PFAPA)
AND Periodicity* AND (Therapy/Broad [ﬁlter]) n = 93.
Several case series have shown good results, with reports of
complete resolution of symptoms in patients with PFAPA who
underwent surgery (tonsillectomy)12–16 (C). However, there is
controversy regarding this approach17 (C). A systematic review
analyzing evidence on the role of tonsillectomy or adenoidec-
tomy in treating children with PFAPA syndrome found that
the success of the surgical approach is widely variable, with
studies demonstrating complete resolution of symptoms, and
others which did not identify any clinical improvement18
(A). A meta-analysis published in 2010 noted that, when
comparing the clinical treatment with corticosteroids versus
tonsillectomy, both therapies were equally effective in treat-
ing PFAPA. However, surgical intervention was considered the
best choice in the long run19 (A). Taking into account the possi-
bility of surgical risk related to tonsillectomy, surgery should
be considered in those patients in whom the symptoms of























































Or e v b r a s r e u m a t
FAPA clearly affect their quality of life or in those with poor
esponse to medical treatment.
A randomized clinical trial carried out in order to assess the
ffectiveness of tonsillectomy in children with a mean age of
.1 years (n = 26) and who  had suffered at least ﬁve episodes
elated to PFAPA syndrome found that all children who had
ndergone tonsillectomy (n = 14) were free of symptoms after
 6-month follow-up, with disappearance of fever episodes.
n the other hand, in the group under clinical surveillance
nly in half of these patients the symptoms subsided (6/12)20
B). Four of the 14 children who underwent surgical treatment
howed a febrile episode compatible with periodic fever within
ix months after surgery versus 34 episodes reported by all chil-
ren in the control group (0.05 episodes per child/month in
he surgical group versus 0.47 episodes per child/month in the
ontrol group, based on a 6-month period of follow-up). After a
-month follow-up, 42% of the children ascribed to the control
roup were submitted to surgical treatment due to persistence
f symptoms. In this study, no complications related to surgery
ere identiﬁed20 (B).
In another non-blinded, randomized, clinical trial, which
lso analyzed the role of tonsillectomy (with adenoidectomy),
hildren diagnosed with PFAPA syndrome (n = 39) were allo-
ated for surgical treatment (n = 19) or clinical follow-up only
control group n = 20), and both groups received treatment
ith corticosteroids21 (B). In this study, at the end of an 18-
onth period of follow-up the authors identiﬁed a complete
esolution of symptoms in 13 patients; 12 of these patients
12/19) had been randomized for surgical treatment. Over-
ll, 12 episodes of PFAPA syndrome were identiﬁed in the
roup undergoing surgery versus 179 episodes recorded in the
ontrol group during the 18-month follow-up (0.04 episodes
er child/month in the surgical group versus 0.5 episodes per
hild/month in the control group; RR = 0.07; 95% CI: 0.04–0.13).
he proportion of patients who experienced resolution of
ymptoms with surgery versus clinical follow-up was 63% ver-
us 5% respectively21 (B).
ecommendation
he evidence supporting the indication for surgical treatment
tonsillectomy with or without adenoidectomy) of patients
ith PFAPA syndrome is based on two non-blinded, random-
zed clinical trials that included small numbers of patients22,23
A). Although these studies demonstrate effectiveness of sur-
ical treatment with immediate and long-term resolution
f symptoms related to this syndrome, each case must be
ssessed individually, and further studies should be con-
ucted. Taking into account the possibility of a surgical risk
elated to tonsillectomy, some authors suggest that surgery
hould be considered in those patients in whom the symp-
oms of PFAPA clearly affect their quality of life or in those
ith poor response to medical treatment.22
hat  is  the  role  of  corticosteroids  in  the  treatment
f periodic  fever,  aphthous  stomatitis,  pharyngitis
nd adenitis  syndrome?trategy
Pharyngitis OR Pharyngitides OR Lymphadenitis OR Adenitis
R Stomatitis, Aphthous) AND (Fever, Periodic OR Periodicity 0 1 6;5  6(1):52–57 55
OR Syndrome OR PFAPA) AND (Steroids OR Glucocorticoid* OR
Prednisone OR Dexamethasone) = 208.
Series and case reports have demonstrated the occurrence
of fever resolution in less than 6 h, and of the other symptoms
in less than 48 h after an initial dose of prednisone 1–2 mg/kg,
with a second dose of 0.5–1 mg/kg that may be repeated if the
disease has not been controlled within 48–72 h3,7,24–27 (C).
A case series with 12 children showed immediate fever
improvement in nine patients after the dose of prednisone,
and the interval between attacks was extended from 21 days
(mean interval prior to treatment) to 133 days post treatment
(p = 0.007)2 (C). And a decrease of 50% in the time between
attacks was already assigned to corticosteroids.4
In adults with PFAPA, prednisone at a dose of 60 mg/day
administered at the onset of symptoms, improved fever; and a
signiﬁcant improvement of other symptoms, particularly with
respect to a decrease of tonsillar exudate and oral ulcers, was
also observed. During follow-up, eight of the 15 patients evalu-
ated exhibited an increased incidence of crisis episodes, with
recurrence at 3-week intervals after the beginning of treat-
ment with corticosteroids4 (C).
In a randomized clinical trial28 (B) with 41 children, treat-
ment with low doses of prednisone was compared with higher
doses of this drug. The children were divided into two groups
to receive 0.5 mg/kg/day or 2 mg/kg/day. In the ﬁrst group, the
fever ceased in 8–12 h, and in the second group in 6–8 h. The
other symptoms disappeared after 24 h in both groups. There
was no increase in the interval between crises with pred-
nisone in these two doses. The adverse effects observed were
restlessness and sleep disturbance, which can be minimized
by administering the dose of the corticosteroid at least 4–6 h
before bedtime.
Recommendation
The use of prednisone at a dose of 1–2 mg/kg body weight at
the onset of fever in patients with PFAPA has proved effective
in a number of series and case reports and in a random-
ized study. Despite the small samples in these trials, and also
taking into account that these were non placebo-controlled
studies, the use of prednisone on demand probably is a valid
therapeutic strategy for crises of this syndrome, with a low
risk of adverse events.29 The best evidence is still needed to
support its use in PFAPA patients.
What  is  the  role  of  IL-1  inhibitors  in  the  treatment
of periodic  fever,  aphthous  stomatitis,  pharyngitis
and adenitis  syndrome?
Strategy
(Pharyngitis OR Pharyngitides OR Lymphadenitis OR Adenitis
OR Stomatitis, Aphthous) AND (Fever, Periodic OR Periodicity
OR Syndrome OR PFAPA) AND (Interleukin 1 Receptor Antag-
onist Protein OR Anakinra OR Kineret OR Antril OR Receptors,
Interleukin) n = 19.
Inﬂammatory mechanisms adjacent to PFAPA are still
unknown. One study showed increased serum cytokines IL-1
and IL-6, when compared to the control group; and a decrease
in serum levels of anti-inﬂammatory cytokines, particularly
IL-4 and IL-1030 (C).
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One study looked at the blood proﬁle, inﬂammatory mark-
ers and cytokine levels in 15 children with PFAPA in and
off-febrile episodes. The ability of monocytes to secrete IL-
1 was assessed by ELISA; and active secretion of IL-1 was
visualized by Western blotting. During febrile periods, stim-
ulated monocytes secreted signiﬁcantly more  IL-1 versus
off-febrile episodes. The authors concluded that an IL-1
release dysregulation by monocytes occurs in patients with
PFAPA syndrome, and approximately 20% had NLRP3 variants,
suggesting that inﬂammasome-related genes may be involved
in this auto-inﬂammatory syndrome31 (C). In one case report,
a 27-year old adult patient who exhibited resistance against
conventional treatment with prednisone and tonsillectomy
and featuring more  than 10 attacks/year was treated with the
IL-1 inhibitor, anakinra, at a dose of 100 mg/day. After a 6-
month follow-up, the patient remained asymptomatic, with
no signal of recurrence32 (C).
In a randomized clinical trial with 21 children, blood sam-
ples of children with PFAPA, of children with other hereditary
periodic fever, and of healthy children were analyzed. In those
patients with PFAPA a signiﬁcant elevation of C3, IL-18 and
IL-1 in febrile periods was noted. In the same study, ﬁve
patients with PFAPA were treated with a recombinant IL-1
receptor antagonist; in all patients, a quick clinical response
was observed5 (B).
Recommendation
While the results obtained with IL-1 inhibitors are promis-
ing, the studies are limited to a few case reports, requiring
randomized clinical trials to deﬁne the role of IL-1 inhibitors
in the management of PFAPA.
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